Important pharmacy news and late-breaking industry information updated daily.

While the annual conference focuses on opioid abuse, more programming on appropriate pain management was included this year

FDA has approved epoetin alfa-epbx (Retacrit—Hospira) as a biosimilar to epoetin alfa (Epogen/Procrit—Amgen) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine for individuals with HIV.

New guidelines focus on diagnosis, infection prevention, and more

Agency calling it an intermittent supply chain shortage

Top federal health officials on Monday defended President Donald Trump's plan to reduce drug prices Monday after critics charged it left out more aggressive measures Trump advocated when he was a presidential candidate.

Study in JAMA Internal Medicine: Industry pays $9 million

President Trump vowed on Friday to "bring soaring drug prices back down to earth" by promoting competition among pharmaceutical companies, but he dropped the proposals of his presidential campaign, deciding not to have the federal government directly negotiate lower drug prices for Medicare.

FDA has issued four new warning letters to manufacturers and retailers for selling e-liquids used in e-cigarettes with labeling and/or advertising that resembles child-friendly food products. One of the companies that received a warning letter was also cited for illegally selling the product to a minor.

FDA on Wednesday said the EpiPen emergency treatment for allergic reactions is in short supply in the United States because of manufacturing delays. Mylan, which sells EpiPens that are manufactured at a Pfizer plant, said some pharmacies lacked supply, but patients could find the drug at other pharmacies.

George Barrett, executive chairman of Cardinal Health, apologized Tuesday for the company’s role in facilitating the flow of highly addictive analgesics into U.S. communities, the first time a corporation has expressed regret for involvement in the opioid crisis.